NIKOLA CORP (NKLA)

US6541101050 - Common Stock

0.6439  -0.02 (-2.44%)

After market: 0.6511 +0.01 (+1.12%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NKLA. NKLA was compared to 131 industry peers in the Machinery industry. NKLA may be in some trouble as it scores bad on both profitability and health. NKLA is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year NKLA has reported negative net income.
In the past year NKLA has reported a negative cash flow from operations.
In the past 5 years NKLA reported 4 times negative net income.
In the past 5 years NKLA always reported negative operating cash flow.

1.2 Ratios

NKLA has a Return On Assets of -75.79%. This is amonst the worse of the industry: NKLA underperforms 90.70% of its industry peers.
Looking at the Return On Equity, with a value of -134.36%, NKLA is doing worse than 90.70% of the companies in the same industry.
Industry RankSector Rank
ROA -75.79%
ROE -134.36%
ROIC N/A
ROA(3y)-69.65%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.18%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NKLA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

NKLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NKLA has been increased compared to 1 year ago.
NKLA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NKLA has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -3.77, we must say that NKLA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.77, NKLA is doing worse than 87.60% of the companies in the same industry.
A Debt/Equity ratio of 0.37 indicates that NKLA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.37, NKLA is in line with its industry, outperforming 55.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -3.77
ROIC/WACCN/A
WACC8.72%

2.3 Liquidity

NKLA has a Current Ratio of 2.16. This indicates that NKLA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NKLA (2.16) is comparable to the rest of the industry.
A Quick Ratio of 1.92 indicates that NKLA should not have too much problems paying its short term obligations.
NKLA's Quick ratio of 1.92 is fine compared to the rest of the industry. NKLA outperforms 76.74% of its industry peers.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.92

6

3. Growth

3.1 Past

NKLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.62%, which is quite impressive.
Looking at the last year, NKLA shows a very negative growth in Revenue. The Revenue has decreased by -28.61% in the last year.
Measured over the past years, NKLA shows a very strong growth in Revenue. The Revenue has been growing by 610.32% on average per year.
EPS 1Y (TTM)21.62%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q70.27%
Revenue 1Y (TTM)-28.61%
Revenue growth 3Y610.32%
Revenue growth 5YN/A
Revenue growth Q2Q75.79%

3.2 Future

NKLA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.54% yearly.
Based on estimates for the next years, NKLA will show a very strong growth in Revenue. The Revenue will grow by 158.27% on average per year.
EPS Next Y52.67%
EPS Next 2Y27.95%
EPS Next 3Y22.54%
EPS Next 5Y15.54%
Revenue Next Year344.38%
Revenue Next 2Y256.48%
Revenue Next 3Y228.78%
Revenue Next 5Y158.27%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NKLA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NKLA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NKLA's earnings are expected to grow with 22.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.95%
EPS Next 3Y22.54%

0

5. Dividend

5.1 Amount

No dividends for NKLA!.
Industry RankSector Rank
Dividend Yield N/A

NIKOLA CORP

NASDAQ:NKLA (4/19/2024, 7:06:37 PM)

After market: 0.6511 +0.01 (+1.12%)

0.6439

-0.02 (-2.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap860.01M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.79%
ROE -134.36%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.16
Quick Ratio 1.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)21.62%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y52.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-28.61%
Revenue growth 3Y610.32%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y